Navigation Links
Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Date:5/13/2008

SAN FRANCISCO, May 13 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), today announced that Peter Strumph, Chief Executive Officer of Nile, will present at the Rodman & Renshaw 5th Annual Global Healthcare Conference at 10:00 a.m. CET on Tuesday, May 20th at Le Meridian Beach Plaza Hotel in Monte Carlo, Monaco. Mr. Strumph will provide a company overview and update on the status of Nile's current clinical development programs.

The presentation will be webcast live and can be accessed by visiting the Investor Relations section of Nile's website at http://www.nilethera.com. The webcast will be archived for 90 days. Additional information regarding the Rodman & Renshaw Global Healthcare Conference can be accessed at http://www.rodmanandrenshaw.com/conferences?id=18.

About Nile Therapeutics

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical need. Nile is initially focusing its efforts on developing its lead compound, CD-NP, a novel chimeric peptide in clinical studies for the treatment of heart failure, and 2NTX-99, a small molecule, pre-clinical, anti-atherothrombotic agent with nitric oxide donating properties. A key component of the company's strategy is to acquire the global rights to additional compounds to expand its portfolio. More information on Nile can be found at http://www.nilethera.com.

This press release contains forward-looking statements within the meaning of the Private Sec
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
2. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
3. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
4. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
5. President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
6. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
7. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
8. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
9. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
10. Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
11. Cell Therapeutics, Inc. (CTI) to Report 2008 First Quarter and Financial Results on May 8
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... NY (PRWEB) September 11, 2014 Entries are ... Awards—the only awards where peers and colleagues within the healthcare ... Pharma Choice Awards recognize the very best in healthcare creative ... judged by peers in the health and wellness industry. All ... vote for the top campaigns in each category. , ...
(Date:9/11/2014)... 11, 2014 Genera Energy Inc ... and supply chain advancements, recently introduced its newest feedstock ... delivers a consistent biomass product to a customer’s specifications ... lower cost. , “After producing and harvesting a ... to convert a field crop into a uniform format ...
(Date:9/11/2014)... (PRWEB) September 11, 2014 Central Florida ... announce his partnerships with several Brevard County animal hospitals ... Christiansen has been working in the area since January ... animals since 2008, and is happy to now offer ... years Dr. Christiansen has used stem cell therapy with ...
(Date:9/10/2014)... , Schweiz, September 11, 2014 ... Eierstockkrebs, die bei der Jahresversammlung der Europäischen ... bekräftigen die komplette Tumorprofilierung als "Wendepunkt" für ... Caris Registry™ zeigte ein deutlich längeres Überleben ... Eileiter- oder primär peritonealem Krebs, denen Behandlungen ...
Breaking Biology Technology:PM360 Now Accepting Entries for 2014 Pharma Choice Awards 2Genera Energy’s BIN-SPEC™ Reduces Biomass Feedstock Variability 2Genera Energy’s BIN-SPEC™ Reduces Biomass Feedstock Variability 3Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond 2Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond 3Verbesserte Überlebensrate von Patientinnen mit Eierstockkrebs, die Behandlungen nach Anleitung durch komplette Tumorprofilierung erhalten 2Verbesserte Überlebensrate von Patientinnen mit Eierstockkrebs, die Behandlungen nach Anleitung durch komplette Tumorprofilierung erhalten 3Verbesserte Überlebensrate von Patientinnen mit Eierstockkrebs, die Behandlungen nach Anleitung durch komplette Tumorprofilierung erhalten 4Verbesserte Überlebensrate von Patientinnen mit Eierstockkrebs, die Behandlungen nach Anleitung durch komplette Tumorprofilierung erhalten 5
... in a series of articles on developing start-up companies ... article focused on the tax law implications of employees ... unemployment insurance. , , Madison, Wis. ... test for determining independent contractor status. Although this test ...
... that a CIO's head has to be on a swivel. ... consistent theme during the Fusion 2007 CEO-CIO Symposium , ... directions, and risk management has surpassed security as the paramount ... opening keynote, where John Swainson, chief executive of CA ...
... web-centric business sector continued its crash in 2001, the directors ... their Wisconsin-based business unit. Their decision was only delayed when ... meeting in New York scheduled for that tragic day. , ... Dan Maynard pleaded with board members to keep the division ...
Cached Biology Technology:Early Stage, Step 8: Misclassifying workers brings risk 2Early Stage, Step 8: Misclassifying workers brings risk 3Early Stage, Step 8: Misclassifying workers brings risk 4Early Stage, Step 8: Misclassifying workers brings risk 5Fusion 2007: IT threats make risk management paramount 2Fusion 2007: IT threats make risk management paramount 3Connecture's Maynard finds IT business opportunity in adversity 2Connecture's Maynard finds IT business opportunity in adversity 3Connecture's Maynard finds IT business opportunity in adversity 4Connecture's Maynard finds IT business opportunity in adversity 5Connecture's Maynard finds IT business opportunity in adversity 6
(Date:9/11/2014)... are more than 300,000 cases of Lyme disease in the ... to the CDC were concentrated heavily in the Northeast and ... In fact, the disease gets its name from the northeastern ... However, a new article published in the Journal of ... disease Ixodes scapularis , also known as blacklegged ...
(Date:9/11/2014)... known for her work as a high-energy experimental particle ... international consortium of scientists who detected the Higgs boson ... Hadron Collider. , But Bean, a professor of physics ... a long-running passion for engaging the public with science. ... artists and museum educators in the creation of "Quarked," ...
(Date:9/11/2014)... A new study led by the Wildlife Conservation ... where leopards prowl at night, it,s not livestock that,s ... friend. , The study, which looked at scat samples ... that 87 percent of their diet was made up ... most common prey item at 39 percent and domestic ...
Breaking Biology News(10 mins):Physics researcher to advise faith-based office in US Department of State 2Study: Cat bites dog 2
... men die of prostate cancer. It,s Australia,s second worst ... cancer on women. Current therapies for prostate ... the tumour or cutting off the supply of the ... impotence. Growing cells need an essential nutrient, the ...
... of the scientific and technical publishing business of John Wiley ... Society Located in Taipei have signed an agreement to closely ... Chemical Society . The journal will be available online from ... most extensive multidisciplinary collections of online resources, used by 10 ...
... distinct from hematopoietic cells, are an essential component ... for the long-term maintenance of hematopoietic stem cells ... stromal cells regulate the proliferation and differentiation of ... factors and extracellular matrix, and through physical cell-cell ...
Cached Biology News:Starving prostate cancer 2Journal of the Chinese Chemical Society expands international reach with Wiley-VCH 23-D long-term bone marrow culture to analyze stromal cell biological function 2
...
...
... derived from the Spodoptera frugiperda Sf21 cell line ... transfections, plaque assays, virus production, and protein expression. ... optimizes recovery of viable cells after thawing. They ... Cell Medium and can also be grown in ...
The PROTEAN II slab gel casting stand is a component of the PROTEAN II XL and xi casting apparatus. It is supplied with gaskets....
Biology Products: